{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:08:15Z","timestamp":1789474095512,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.acra.2022.10.011","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T08:50:50Z","timestamp":1669366250000},"page":"1408-1418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["18F-FDG PET-Based Combined Baseline and End-Of-Treatment Radiomics Model Improves the Prognosis Prediction in Diffuse Large B Cell Lymphoma After First-Line Therapy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3215-3365","authenticated-orcid":false,"given":"Yingpu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongluo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baocong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-9042","authenticated-orcid":false,"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.acra.2022.10.011_bib0001","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.acra.2022.10.011_bib0002","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","article-title":"Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","volume":"101","author":"Perry","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","article-title":"(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients","volume":"51","author":"Weiler-Sagie","year":"2010","journal-title":"J Nucl Med"},{"issue":"Suppl 7","key":"10.1016\/j.acra.2022.10.011_bib0004","doi-asserted-by":"crossref","first-page":"vii78","DOI":"10.1093\/annonc\/mds273","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Tilly","year":"2012","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.acra.2022.10.011_bib0005","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.6004\/jnccn.2021.0054","article-title":"NCCN Guidelines(R) Insights: B-Cell Lymphomas, Version 5.2021","volume":"19","author":"Zelenetz","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.acra.2022.10.011_bib0006","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.23688","article-title":"Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma","volume":"89","author":"El-Galaly","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.acra.2022.10.011_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/bjh.16691","article-title":"Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial","volume":"192","author":"Gleeson","year":"2021","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.acra.2022.10.011_bib0008","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.acra.2022.10.011_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6004\/jnccn.2016.0023","article-title":"Diffuse Large B-Cell Lymphoma Version 1.2016","volume":"14","author":"Zelenetz","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"27","key":"10.1016\/j.acra.2022.10.011_bib0010","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2022.10.011_bib0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2019.09.027","article-title":"Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial","volume":"124","author":"Schmitz","year":"2020","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.acra.2022.10.011_bib0012","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00259-019-04309-4","article-title":"Prognostic value of metabolic tumour volume on baseline (18)F-FDG PET\/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI","volume":"46","author":"Shagera","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.acra.2022.10.011_bib0013","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1007\/s00330-020-06815-8","article-title":"Baseline (18)F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy","volume":"30","author":"Aide","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2022.10.011_bib0014","article-title":"(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma","author":"Eertink","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2022.10.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-022-05717-9","article-title":"Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma","author":"Jiang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.acra.2022.10.011_bib0016","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2967\/jnumed.121.262205","article-title":"(18)F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study","volume":"63","author":"Burggraaff","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.acra.2022.10.011_bib0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.acra.2022.10.011_bib0018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"10.1016\/j.acra.2022.10.011_bib0019","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational Radiomics System to Decode the Radiographic Phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.acra.2022.10.011_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0021","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1038\/s41598-021-87598-w","article-title":"Robustness of radiomic features in CT images with different slice thickness, comparing liver tumour and muscle","volume":"11","author":"Escudero Sanchez","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0022","doi-asserted-by":"crossref","first-page":"10545","DOI":"10.1038\/s41598-018-28895-9","article-title":"Voxel size and gray level normalization of CT radiomic features in lung cancer","volume":"8","author":"Shafiq-Ul-Hassan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2022.10.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-015-0068-x","article-title":"Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool","volume":"15","author":"Taha","year":"2015","journal-title":"Bmc Med Imaging"},{"issue":"14","key":"10.1016\/j.acra.2022.10.011_bib0024","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.acra.2022.10.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237587","article-title":"FeAture Explorer (FAE): A tool for developing and comparing radiomics models","volume":"15","author":"Song","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1145\/1007730.1007735","article-title":"A study of the behavior of several methods for balancing machine learning training data","volume":"6","author":"Batista","year":"2004","journal-title":"SIGKDD Explor"},{"issue":"3","key":"10.1016\/j.acra.2022.10.011_bib0027","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cpet.2019.03.001","article-title":"End-of-Treatment PET\/Computed Tomography Response in Diffuse Large B-Cell Lymphoma","volume":"14","author":"Kostakoglu","year":"2019","journal-title":"PET Clin"},{"issue":"7","key":"10.1016\/j.acra.2022.10.011_bib0028","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.2020005846","article-title":"Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP","volume":"137","author":"Freeman","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12149-020-01542-y","article-title":"The prognostic role of end-of-treatment FDG-PET\/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event","volume":"35","author":"Annunziata","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"25","key":"10.1016\/j.acra.2022.10.011_bib0030","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood.2019003277","article-title":"Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial","volume":"135","author":"Schoder","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.acra.2022.10.011_bib0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00259-015-3164-9","article-title":"Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET\/CT (FDG-PET\/CT) performed for surveillance in asymptomatic lymphoma patients in first remission","volume":"43","author":"Morbelli","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2022.10.011_bib0032","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eswa.2016.12.035","article-title":"Learning from class-imbalanced data: Review of methods and applications","volume":"73","author":"Haixiang","year":"2017","journal-title":"Expert Syst Appl"},{"issue":"2","key":"10.1016\/j.acra.2022.10.011_bib0033","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00259-018-4138-5","article-title":"Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer","volume":"46","author":"Moon","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"41","key":"10.1016\/j.acra.2022.10.011_bib0034","doi-asserted-by":"crossref","first-page":"67302","DOI":"10.18632\/oncotarget.11693","article-title":"Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0035","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1038\/emm.2017.165","article-title":"The significance of intertumor and intratumor heterogeneity in liver cancer","volume":"50","author":"Liu","year":"2018","journal-title":"Exp Mol Med"},{"issue":"9","key":"10.1016\/j.acra.2022.10.011_bib0036","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.18632\/oncotarget.7067","article-title":"Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival","volume":"7","author":"Morris","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.acra.2022.10.011_bib0037","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.119.238923","article-title":"Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium","volume":"62","author":"Barrington","year":"2021","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2022.10.011_bib0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.120.242412","article-title":"Deep-Learning (18)F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma","volume":"62","author":"Capobianco","year":"2021","journal-title":"J Nucl Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222005487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222005487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:57:03Z","timestamp":1761037023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633222005487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1076633222005487"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2022.10.011","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-FDG PET-Based Combined Baseline and End-Of-Treatment Radiomics Model Improves the Prognosis Prediction in Diffuse Large B Cell Lymphoma After First-Line Therapy","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2022.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}